A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Clinical trial NCT04516447 · RECRUITING

Trial details

NCT number: NCT04516447
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2020-10-26
Primary completion: 2028-06-30
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.